Objective-Previously, we demonstrated the relevance for endothelial carcinoembryonic antigen−related cell adhesion molecule 1 (CEACAM1) expression in collateral formation. However, a proarteriogenic role for CEACAM1 + myeloid cells is unknown. Here, we investigated the contribution of CEACAM1 + myeloid cells on collateral formation. Methods and Results-Collateral growth and vascular remodeling were analyzed in CEACAM1-competent and CEACAM1 null mice after femoral artery ligation in hindlimb ischemia. Reperfusion of the adductor muscles was evaluated by Laser Doppler measurements and microcomputed tomography imaging. In CEACAM1 null mice, poor reperfusion and reduced collateral formation were observed, accompanied by reduction in arterial diameters. Using flow cytometry, we identified an increase of the muscle-resident CD11b + /granulocyte receptor-1 + (Gr-1 + ) population in CEACAM1 null mice only, pointing toward a CEACAM1-dependent functional deviation. Direct and reciprocal bone marrow transplantations between CEACAM1-competent and CEACAM1 null mice, and antibody-mediated depletion of the CD11b + /Gr-1 + population, confirmed the requirement of CEACAM1 expression on the CD11b + /Gr-1 + population for reestablishment of perfusion after arterial occlusion. Conclusion-CEACAM1 expression on CD11b + /Gr-1 + myeloid cells is a prerequisite for adequate collateral formation.
V ascular occlusion initiates mechanisms to reestablish local blood supply. Angiogenesis, the sprouting of capillaries, is distinguished from arteriogenesis, the growth of collateral arteries from preexisting arteriolar anastomoses. During arteriogenesis, CD11b + myeloid cells, neutrophils, monocytes, and macrophages are recruited after endothelial cell activation by hemodynamic alterations. [1] [2] [3] They extravasate, accumulate in the adventitia and perivascular space, and trigger collateral growth by liberation or secretion of growth factors and matrix metalloproteinases. 1 Recently, Kim et al 4 demonstrated enhanced neovascularization by local injection of adductor-derived granulocyte receptor-1 (Gr-1) dim /CD11b + cells in murine hindlimb ischemia.
The proangiogenic role of endothelial carcinoembryonic antigen−related cell adhesion molecule 1 (CEACAM1) has been described. [5] [6] [7] [8] CEACAM1 is a highly glycosylated transmembrane protein of the immunoglobulin superfamily and is expressed on endothelia, epithelia, and leukocytes, including macrophages and granulocytes. 9 Its endothelial overexpression correlated with increased tumor angiogenesis and vessel maturation in mammary carcinogenesis, 8 whereas in CEACAM1 null hosts, tumor vessels were instable, leaky, and facilitated pulmonary metastasis. In a model for chronic cutaneous inflammation, 5 CEACAM1 + myeloid cells support angiogenesis and wound healing. Therefore, the present study was conducted to investigate whether CEACAM1 + myeloid cells have a proarteriogenic function.
Materials and Methods

Animal Experiments
Male mice (C57BL/6J, 8-12 weeks old) were maintained according to the Federation of European Laboratory Animal Science Associations (FELASA) guidelines for the care and use of experimental animals. The Materials and Methods are detailed in the online-only Data Supplement.
Results
We observed increased collateral formation in CEACAM1competent mice 6 days after surgical occlusion of the femoral artery ( Figure 1A and 1B). Immediately after ligation, perfusion rates dropped to ≈6% in both mouse lines. Three days after occlusion, reestablishment of perfusion in the adductor muscles was observed in CEACAM1-competent mice and to a significantly lesser extent, in CEACAM1 null (Ceacam1 −/− ) mice (22.70±2.29% versus 15.58±1.56%, respectively; Figure  1A and 1C). On day 6, acceleration of recovery and reestablishment of perfusion in CEACAM1-competent mice over Ceacam1 −/− mice became even more evident (50.62±1.37% versus 33.07±2.28%; Figure 1C ). Additionally, the luminal diameters of arteries were significantly increased in the adductor muscles of CEACAM1-competent mice compared with Ceacam1 −/− mice ( Figure 1D and 1E) .
Using direct and reverse bone marrow transplantation between CEACAM1-competent donors and Ceacam1 −/− recipients, we demonstrate that transfer of CEACAM1 + BM reconstituted adequate collateral formation, irrespective of the Ceacam1 genotype of the recipient. On the contrary, introduction of CEACAM1 null grafts into wild-type (WT) mice compromised arteriogenesis, and the number of collaterals was decreased opposed to WT or Ceacam1 −/− mice that received WT BM (WT+WT BM, 9.8±0.5; Ceacam1 −/− +WT BM, 9.8±0.7; WT+Ceacam1 −/− BM, 6.4±1.0; Figure 2A−2C) . Thus, we characterized myeloid and hematopoietic cell populations in peripheral blood, BM, and adductors of the different mouse lines.
In the adductors of Ceacam1 −/− mice, 7 days after ligation of the femoral artery, only the CD11b + /Gr-1 + population exhibited a relative local increase ( Figure 2D ; Figure I in the online-only Data Supplement). Antibody-mediated depletion of this population conveyed proof that perfusion recovery is sensitive toward elimination of CEACAM1-expressing CD11b + Gr-1 + cells but not CEACAM1-negative CD11b + Gr-1 + cells ( Figure 2E ).
Discussion
We describe for the first time that CEACAM1 + myeloid cells are essential for adequate arteriogenesis in a model of murine hindlimb ischemia and that their presence increases the number of collateral arteries and collateral vessel calibers. Preexisting collateral diameters in naïve mice were not altered in CEACAM1 null mice, immediately after vessel occlusion, which is different from platelet endothelial cell adhesion molecule 1−knockout mice compared with wild-type littermates. 10 Therefore, the immunoglobulin family members platelet endothelial cell adhesion molecule and CEACAM1 mediate their proarteriogenic effects via different mechanisms or differentially modulate the arteriogenic activity of myeloid cells. Because only transplantation of WT BM into Ceacam1 −/− mice reintroduced complete recovery in the arteriogenic response, we confirmed the requirement for CEACAM1 + BM−derived cells for resolution of 
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November 2012 inflammation during wound healing and vascular remodeling 5 : Accumulation of the CD11b + /Gr-1 + population in the collateral region of Ceacam1 −/− mice suggests, more probably, a negative regulatory role of CEACAM1 − /CD11b + /Gr-1 + cells on collateral growth or an ineffective compensatory response to their functional deficiency. Congruently, depletion of CEACAM1 + /CD11b + /Gr-1 + corrupted reestablishment of perfusion, whereas depletion of CEACAM1 − /CD11b + /Gr-1 + did not convey any effects. Because the monocytic CD11b + / Ly-6C + and granulocytic CD11b + /Ly-6G + populations did not show any deviations in their distribution or relative quantities in the different reservoirs, the CD11b + /Gr-1 + cells most likely belong to a myeloid-derived suppressor cell population. This is in agreement with a previous report stating that vessel maturation is poor in the presence of CEACAM1 − CD11b + / Gr-1 + cells. 11 Functional characterization of CEACAM1 + / CD11b + /Gr-1 + cells in vascular remodeling requires further investigation. 
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